At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NLR VanEck Uranium+Nuclear Energy ETF
Market Closed 09-27 16:00:00 EDT
84.83
+0.33
+0.39%
盘后84.83
+0.000.00%
19:41 EDT
High85.12
Low84.21
Vol51.29K
Open84.82
D1 Closing84.50
Amplitude1.08%
Mkt Cap247.42M
Tradable Cap247.42M
Total Shares2.92M
T/O4.35M
T/O Rate1.76%
Tradable Shares2.92M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Uranium producers rally as Constellation Energy plans Three Mile Island restart
Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses
Indaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting
Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes equity securities and depositary receipts issued by companies involved in uranium and nuclear energy. The fund is non-diversified.